Clinical Trials & Research Covid-19

Hydroxychloroquine and chloroquine are classified as anti-malarial drugs. They are commonly used to treat and prevent malaria, a mosquito-borne infectious disease caused by parasites. These drugs work by interfering with the growth and reproduction of the malaria parasites in the body. While they have been used for other conditions such as autoimmune diseases, their primary indication is for the treatment and prevention of malaria. Therefore, the correct answer is Anti-Malarial.

Novavax's vaccine is designed to produce antibodies that can prevent the virus from infecting its host by targeting the spike protein. The company selected its vaccine candidate in April after observing a robust immune response in animal testing. The name of the vaccine is NVX-CoV2373. Therefore, all of the statements provided are true.

Plasma is the liquid part of the blood, so statement A is true. It is not made up of only protein, as it also contains other components such as water, electrolytes, hormones, and waste products. However, plasma does consist of antibodies, which are proteins produced by the immune system to help fight against pathogens. Therefore, statement C is also true.

The correct answer is Solidarity. The World Health Organisation (WHO) and its partners have launched the Solidarity international clinical trial to find an effective treatment for COVID-19. This trial aims to evaluate the safety and efficacy of different drugs and drug combinations in treating COVID-19 patients. By conducting this trial on a global scale, WHO and its partners are pooling resources and collaborating with countries around the world to find the most effective treatment options for the disease.

The given answer is correct because all the statements mentioned are true. Antiviral drugs are designed to inhibit the replication of viruses or prevent them from infecting cells. They can range from complex biotechnology therapies to older generic drugs. Examples of antiviral drugs include those used for treating HIV and hepatitis C. Therefore, all the statements mentioned in the question are correct.

The correct answer is "World Without COVID." This tool is aimed at matching potential volunteers to new clinical trials. It is designed to help researchers find suitable participants for their studies, ultimately contributing to the development of treatments and vaccines for COVID-19.

Convalescent Plasma Therapy is a treatment method where plasma from recovered individuals is collected and transfused into patients who are currently infected with the same disease. This therapy is used to provide passive immunity to the patients by transferring antibodies present in the plasma. It has been used for outbreaks caused by Ebola virus, SARS (Severe Acute Respiratory Syndrome), and MERS (Middle East Respiratory Syndrome). Therefore, the correct answer is "All the above".

Remdesivir is an antiviral medicine that has been used in clinical trials by Gilead Sciences for COVID-19 treatment. It is a broad-spectrum antiviral drug that inhibits the replication of RNA viruses, including coronaviruses. Remdesivir has shown promise in reducing the severity and duration of symptoms in COVID-19 patients and has received emergency use authorization from the FDA for the treatment of hospitalized patients with severe COVID-19. It is one of the most widely studied antiviral drugs for COVID-19 and has been approved for emergency use in several countries.

Both A and B are correct answers because Convalescent Plasma and Plasma Therapy are two names used interchangeably to refer to the therapy in which blood is infused from recovered COVID-19 patients to other critical COVID-19 patients.

Fujifilms is the correct answer because the question is asking which entity is conducting tests on favipiravir as a COVID-19 treatment. Out of the options provided, Fujifilms is the only one that is relevant to the topic and is a known pharmaceutical company.